(openPR) - For the first time, all "advanced therapies" (gene therapy, somatic cell therapy and tissue engineering products) will be centralised in a single procedure of the newly adopted European Regulation No 1394/2007 ("the Regulation") on advanced therapy medicinal products (ATMPs). This regulation lays down specific
rules concerning the authorisation, supervision and pharmacovigilance of ATMPs and will apply as of 30 December 2008.
The focus of this seminar will be on the required legitimate and regulatory framework regarding ATMP research, authorisation and manufacturing.
FORUM Institute fuer Management, one of the leading professional seminar and conference providers in Europe, offers the seminar "Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT" for the pharmaceutical industry on 9 December 2008 in Frankfurt am Main.
Further information on the seminar and the company you will find under: www.forum-institut.de/veranstaltung.asp?SemNr=0809236
Contact:
Dr. Nadine Jede
Conference Manager
Department Pharma
FORUM Institut fuer Management GmbH, Heidelberg
Vangerowstraße 18
69115 Heidelberg
Germany
Tel. +49 6221 500 655
Fax. +49 6221 500 618 n.jede@forum-institut.de
FORUM Institute is very active and acknowledged in the field of educational seminars and conferences for the pharmaceutical industry. In several areas FORUM has the leading market position. Especially the close co-operation with the regulatory authorities assures the outstanding quality and up-to-dateness of the trainings. Each novel important guideline from the national authorities or the EMEA/CHMP results in a seminar within a short period of time to insure that pharmaceutical industry personnel receives the proper information and training. The speakers are experts from the pharmaceutical industry, service provider, lawyers and national / international authorities.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
